Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Nasal spray flu vaccine approved for home use
FDA Approves First At-Home Flu Vaccine
The wait for a flu shot at your doctor's office or pharmacy may soon be a thing of the past. The U.S. Food and Drug Administration has approved FluMist nasal spray as the first influenza vaccine for self-administration at home.
FDA Approves First Nasal Spray Flu Vaccine You Can Give Yourself at Home
The Food and Drug Administration (FDA) has approved the first-ever influenza vaccine that can be administered at home. It’s a nasal spray vaccine called FluMist, and it’s been
FDA approves FluMist nasal spray flu vaccine — no doctor required
Gaithersburg, Maryland-based MedImmune has received the FDA’s approval of its FluMist nasal spray flu vaccine, meaning no physician needed.
FDA Approves Updated COVID-19 Vaccine for 2024-2025 Season
The fall virus season is upon us, and the U.S. Food & Drug Administration just approved one of the newest tools to protect Americans from severe illness.
FDA approves first flu vaccine that can be self-administered at home
The US Food and Drug Administration on Friday approved the first flu vaccine that does not have to be administered by a health care provider, but it won’t be available in time for this respiratory virus season.
Physician answers questions about first at-home flu vaccine
The U.S. Food and Drug Administration has approved the first at-home flu vaccine that people can self-administer.
Inside Your Health: Self-administered nasal flu vaccine
To help increase vaccination rates, the FDA just approved a new flu vaccine that people will be able to give themselves at home. This new option will be available for next year’s flu season. 5 EYEWITNESS NEWS anchor Leah McLean sat down with KSTP health expert Dr.
Health headlines: A new flu vaccine option you can do at home
In today's health headlines, nearly one in three Americans have an iron deficiency and what to know about repetitive brain injuries in football players. Plus, a new flu vaccine option you can do at home.
In a 1st for US, its FDA approves at-home use of nasal flu vaccine; India’s version yet to gain traction
US's FluMist can now be administered by a healthcare provider or by recipient or caregiver aged 18 or above. India's Nasovac S4 faces hurdles like cost, availability & low acceptance.
dermatologyadvisor
1d
MF59-Adjuvanted Trivalent Influenza Vaccine Favored Among High-Risk Older Adults
The aTIV vaccine provides better protection against influenza-related medical encounters than the HD-TIV vaccine in high-risk older adults.
Live Science
7d
At-home flu vaccine approved by FDA — what to know
People could previously get the nasal spray flu vaccine, called FluMist, from a health care provider, but now they can ...
labiotech
1d
The race for a bird flu vaccine: milestones and breakthroughs
Track the latest bird flu vaccine news, investments, and deals as biotechs respond to rising U.S. cases with innovative ...
The Highland County Press
13h
Influenza vaccinations now available through Adena Health
Adena Health offers flu shots by appointment at any of its family medicine, primary care, and pediatric locations. Flu vaccinations are also available at all Adena urgent care, same-day, and walk-in ...
1d
Inside DC's Public Health Lab ahead of flu season: How samples aid in vaccine creation
If you get swabbed for flu in the District, that sample could end up at D.C.’s Public Health Lab inside the Consolidated ...
6d
FluMist At-Home Nasal Flu Vaccine: How Effective Is It Compared to Regualar Shots?
Is FluMist, the at-home nasal vaccine that was recently approved by the FDA, as effective at preventing illness as ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
FluMist
Nasal spray
United States
COVID-19
Food and Drug Administration
Feedback